International AIDS Vaccine Initiative [Affiliation] AND Parks CL [Author] - Search Results

Year	Number of Results
2008	1
2010	1
2011	1
2013	5
2014	6
2015	3
2016	1
2017	2
2018	1
2019	1
2020	1
2021	1

1

Development of replication-competent viral vectors for HIV vaccine delivery.

Parks CL, Picker LJ, King CR. Parks CL, et al. Curr Opin HIV AIDS. 2013 Sep;8(5):402-11. doi: 10.1097/COH.0b013e328363d389. Curr Opin HIV AIDS. 2013. PMID: 23925000 Free PMC article. Review.

2

Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome.

Martins MA, Gonzalez-Nieto L, Ricciardi MJ, Bailey VK, Dang CM, Bischof GF, Pedreño-Lopez N, Pauthner MG, Burton DR, Parks CL, Earl P, Moss B, Rakasz EG, Lifson JD, Desrosiers RC, Watkins DI. Martins MA, et al. Among authors: parks cl. J Virol. 2020 Nov 23;94(24):e00979-20. doi: 10.1128/JVI.00979-20. Print 2020 Nov 23. J Virol. 2020. PMID: 33028714 Free PMC article.

3

Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference.

Excler JL, Parks CL, Ackland J, Rees H, Gust ID, Koff WC. Excler JL, et al. Among authors: parks cl. Biologicals. 2010 Jul;38(4):511-21. doi: 10.1016/j.biologicals.2010.03.005. Biologicals. 2010. PMID: 20537552

4

Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.

Clarke DK, Nasar F, Chong S, Johnson JE, Coleman JW, Lee M, Witko SE, Kotash CS, Abdullah R, Megati S, Luckay A, Nowak B, Lackner A, Price RE, Little P, Kalyan N, Randolf V, Javadian A, Zamb TJ, Parks CL, Egan MA, Eldridge J, Hendry M, Udem SA. Clarke DK, et al. Among authors: parks cl. J Virol. 2014 Jun;88(12):6690-701. doi: 10.1128/JVI.03441-13. Epub 2014 Apr 2. J Virol. 2014. PMID: 24696472 Free PMC article.

5

The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Mamu-B*08⁺ Rhesus Macaques.

Martins MA, Gonzalez-Nieto L, Shin YC, Domingues A, Gutman MJ, Maxwell HS, Magnani DM, Ricciardi MJ, Pedreño-Lopez N, Bailey VK, Altman JD, Parks CL, Allison DB, Ejima K, Rakasz EG, Capuano S 3rd, Desrosiers RC, Lifson JD, Watkins DI. Martins MA, et al. Among authors: parks cl. J Virol. 2019 Feb 19;93(5):e01626-18. doi: 10.1128/JVI.01626-18. Print 2019 Mar 1. J Virol. 2019. PMID: 30541854 Free PMC article.

6

Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccines.

Clutton G, Carpov A, Parks CL, Dean HJ, Montefiori DC, Hanke T. Clutton G, et al. Among authors: parks cl. AIDS. 2014 Nov 13;28(17):2495-504. doi: 10.1097/QAD.0000000000000468. AIDS. 2014. PMID: 25229267

7

Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.

Martins MA, Wilson NA, Piaskowski SM, Weisgrau KL, Furlott JR, Bonaldo MC, Veloso de Santana MG, Rudersdorf RA, Rakasz EG, Keating KD, Chiuchiolo MJ, Piatak M Jr, Allison DB, Parks CL, Galler R, Lifson JD, Watkins DI. Martins MA, et al. Among authors: parks cl. J Virol. 2014 Jul;88(13):7493-516. doi: 10.1128/JVI.00601-14. Epub 2014 Apr 16. J Virol. 2014. PMID: 24741098 Free PMC article.

8

Mamu-B*17⁺ Rhesus Macaques Vaccinated with env, vif, and nef Manifest Early Control of SIVmac239 Replication.

Martins MA, Tully DC, Pedreño-Lopez N, von Bredow B, Pauthner MG, Shin YC, Yuan M, Lima NS, Bean DJ, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, Magnani DM, Ricciardi MJ, Bailey VK, Altman JD, Burton DR, Ejima K, Allison DB, Evans DT, Rakasz EG, Parks CL, Bonaldo MC, Capuano S 3rd, Lifson JD, Desrosiers RC, Allen TM, Watkins DI. Martins MA, et al. Among authors: parks cl. J Virol. 2018 Jul 31;92(16):e00690-18. doi: 10.1128/JVI.00690-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29875239 Free PMC article.

9

Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection.

Martins MA, Tully DC, Cruz MA, Power KA, Veloso de Santana MG, Bean DJ, Ogilvie CB, Gadgil R, Lima NS, Magnani DM, Ejima K, Allison DB, Piatak M Jr, Altman JD, Parks CL, Rakasz EG, Capuano S 3rd, Galler R, Bonaldo MC, Lifson JD, Allen TM, Watkins DI. Martins MA, et al. Among authors: parks cl. J Virol. 2015 Nov;89(21):10802-20. doi: 10.1128/JVI.01440-15. Epub 2015 Aug 19. J Virol. 2015. PMID: 26292326 Free PMC article.

10

First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.

Nyombayire J, Anzala O, Gazzard B, Karita E, Bergin P, Hayes P, Kopycinski J, Omosa-Manyonyi G, Jackson A, Bizimana J, Farah B, Sayeed E, Parks CL, Inoue M, Hironaka T, Hara H, Shu T, Matano T, Dally L, Barin B, Park H, Gilmour J, Lombardo A, Excler JL, Fast P, Laufer DS, Cox JH; S001 Study Team. Nyombayire J, et al. Among authors: parks cl. J Infect Dis. 2017 Jan 1;215(1):95-104. doi: 10.1093/infdis/jiw500. Epub 2016 Oct 17. J Infect Dis. 2017. PMID: 28077588 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results